FDA OKs Tysabri Relaunch

International News Service - Sydney,Australia
The FDA has approved a supplemental biologics license application for the reintroduction of Biogen Idec and Elan's multiple sclerosis drug Tysabri, which was ...
See all stories on this topic

Antisense Therapeutics shares soar on FDA decision
egoli.com.au - Australia
... after it was announced that Biogen Idec and Elan Corporation plc had received US Food and Drug Administration (FDA) approval for the reintroduction of Tysabri. ...

Resumed Tysabri Marketing Approved Under Special Prescribing ...
Facts and Comparisons - St. Louis,MO,USA
The FDA has approved the resumed marketing of Biogen Idec’s Tysabri (natalizumab), a monoclonal antibody used as monotherapy in patients with relapsing forms ...